{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:28:20Z","timestamp":1778513300343,"version":"3.51.4"},"reference-count":34,"publisher":"Federa\u00e7\u00e3o das Associa\u00e7\u00f5es de Ginecologia e Obstetr\u00edcia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,18]]},"DOI":"10.61622\/rbgo\/2025rbgo4","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:08:21Z","timestamp":1742486901000},"source":"Crossref","is-referenced-by-count":3,"title":["Gastrin-releasing peptide receptor: a promising new biomarker to identify cervical precursor lesions and cancer"],"prefix":"10.61622","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-4646","authenticated-orcid":false,"given":"Martina","family":"Lichtenfels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8819-6367","authenticated-orcid":false,"given":"Rafaella","family":"Almeida Lima Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-767X","authenticated-orcid":false,"given":"Rossana Veronica","family":"Mendoza L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-7767","authenticated-orcid":false,"given":"Camila","family":"Alves da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5495-0971","authenticated-orcid":false,"given":"Luiz Carlos","family":"Zeferino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4613-5475","authenticated-orcid":false,"given":"Vanesca","family":"de Souza Lino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5779-9752","authenticated-orcid":false,"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0551-4401","authenticated-orcid":false,"given":"Louise","family":"De Brot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3777-3827","authenticated-orcid":false,"given":"Silvia Helena","family":"Rabelo-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6717-8209","authenticated-orcid":false,"given":"Daniela Baumann","family":"Cornelio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1900-0273","authenticated-orcid":false,"given":"Enrique","family":"Boccardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6435-6626","authenticated-orcid":false,"given":"Caroline Brunetto","family":"de Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3588-8877","authenticated-orcid":false,"given":"Lara","family":"Termini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"47794","reference":[{"issue":"2","key":"key20250320154037_B1","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","unstructured":"1 Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203. doi: 10.1016\/S2214-109X(19)30482-6","journal-title":"Lancet Glob Health"},{"issue":"3","key":"key20250320154037_B2","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/ol.2020.11754","article-title":"Cervical cancer in low and middle-income countries","volume":"20","author":"Hull","year":"2020","unstructured":"2 Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, et al. Cervical cancer in low and middle-income countries. Oncol Lett. 2020;20(3):2058-74. doi: 10.3892\/ol.2020.11754","journal-title":"Oncol Lett"},{"key":"key20250320154037_B3","article-title":"Human papillomavirus and related diseases: World","author":"Bruni","year":"2023","unstructured":"3 Bruni L, Albero G, Serrano B, Mena M, Collado JJ, G\u00f3mez D, et al. Human papillomavirus and related diseases: World. Summary Report. 2023 [cited 2024 Apr 10]. Available from: https:\/\/hpvcentre.net\/statistics\/reports\/XWX.pdf","journal-title":"Summary Report"},{"issue":"1","key":"key20250320154037_B4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s44197-023-00172-7","article-title":"Global cervical cancer incidence by histological subtype and implications for screening methods","volume":"14","author":"Wang","year":"2024","unstructured":"4 Wang M, Huang K, Wong MCS, Huang J, Jin Y, Zheng ZJ. Global cervical cancer incidence by histological subtype and implications for screening methods. J Epidemiol Glob Health. 2024 Mar;14(1):94-101. doi: 10.1007\/s44197-023-00172-7","journal-title":"J Epidemiol Glob Health"},{"issue":"12","key":"key20250320154037_B5","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1002\/ijc.29651","article-title":"Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study","volume":"137","author":"Holl","year":"2015","unstructured":"5 Holl K, Nowakowski AM, Powell N, McCluggage WG, Pirog EC, Collas De Souza S, et al. Human papillomavirus prevalence and type-distribution in cervical glandular neoplasias: results from a European multinational epidemiological study. Int J Cancer. 2015;137(12):2858-68. doi: 10.1002\/ijc.29651","journal-title":"Int J Cancer"},{"issue":"6","key":"key20250320154037_B6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","unstructured":"6 Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27. doi: 10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"issue":"5","key":"key20250320154037_B7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","volume":"40","author":"Okunade","year":"2020","unstructured":"7 Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020;40(5):602-8. doi: 10.1080\/01443615.2019.1634030","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"key20250320154037_B8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/s12905-022-02043-y","article-title":"Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review","volume":"22","author":"Petersen","year":"2022","unstructured":"8 Petersen Z, Jaca A, Ginindza TG, Maseko G, Takatshana S, Ndlovu P, et al. Barriers to uptake of cervical cancer screening services in low-and-middle-income countries: a systematic review. BMC Womens Health. 2022;22(1):486. doi: 10.1186\/s12905-022-02043-y","journal-title":"BMC Womens Health"},{"issue":"3","key":"key20250320154037_B9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/pubmed\/fdaa028","article-title":"Trends in access to female cancer screening in Brazil, 2007-16","volume":"43","author":"Passos","year":"2021","unstructured":"9 Passos CM, Sales JB, Maia EG, Caldeira TC, Rodrigues RD, Figueiredo N, et al. Trends in access to female cancer screening in Brazil, 2007-16. J Public Health (Oxf). 2021;43(3):632-8. doi: 10.1093\/pubmed\/fdaa028","journal-title":"J Public Health (Oxf)"},{"key":"key20250320154037_B10","doi-asserted-by":"crossref","first-page":"101460","DOI":"10.1016\/j.gore.2024.101460","article-title":"Public health concern-driven insights and response of low-and middle-income nations to the World health Organization call for cervical cancer risk eradication","volume":"54","author":"Reza","year":"2024","unstructured":"10 Reza S, Anjum R, Khandoker RZ, Khan SR, Islam MR, Dewan SM. Public health concern-driven insights and response of low-and middle-income nations to the World health Organization call for cervical cancer risk eradication. Gynecol Oncol Rep. 2024;54:101460. doi: 10.1016\/j.gore.2024.101460","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"key20250320154037_B11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-0038-1657754","article-title":"Guidelines for HPV-DNA Testing for cervical cancer screening in Brazil","volume":"40","author":"Zeferino","year":"2018","unstructured":"11 Zeferino LC, Bastos JB, Vale DB, Zanine RM, Melo YL, Primo WQ, et al. Guidelines for HPV-DNA Testing for cervical cancer screening in Brazil. Rev Bras Ginecol Obstet. 2018;40(6):360-8. doi: 10.1055\/s-0038-1657754","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"5","key":"key20250320154037_B12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","unstructured":"12 Fontham ET, Wolf AM, Church TR, Etzioni R, Flowers CR, Herzig A, et al. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020;70(5):321-46. doi: 10.3322\/caac.21628","journal-title":"CA Cancer J Clin"},{"key":"key20250320154037_B13","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention","author":"World Health Organization","year":"2021","unstructured":"13 World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: WHO; 2021 [cited 2024 Apr 12]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240030824","edition":"second edition"},{"key":"key20250320154037_B14","doi-asserted-by":"crossref","first-page":"552028","DOI":"10.3389\/fpubh.2020.552028","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"Kombe Kombe","year":"2021","unstructured":"14 Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Front Public Health. 2021;8:552028. doi: 10.3389\/fpubh.2020.552028","journal-title":"Front Public Health"},{"issue":"5-6","key":"key20250320154037_B15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000134478","article-title":"Gastrin-releasing peptide receptor expression in cervical cancer","volume":"73","author":"Cornelio","year":"2007","unstructured":"15 Cornelio DB, Meurer L, Roesler R, Schwartsmann G. Gastrin-releasing peptide receptor expression in cervical cancer. Oncology. 2007;73(5-6):340-5. doi: 10.1159\/000134478","journal-title":"Oncology"},{"issue":"1","key":"key20250320154037_B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.107.07108","article-title":"LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states","volume":"60","author":"Jensen","year":"2008","unstructured":"16 Jensen RT, Battey JF, Spindel ER, Benya RV. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev. 2008;60(1):1-42. doi: 10.1124\/pr.107.07108","journal-title":"Pharmacol Rev"},{"issue":"1","key":"key20250320154037_B17","first-page":"23","article-title":"Gastrin-releasing peptide and cancer","volume":"1766","author":"Patel","year":"2006","unstructured":"17 Patel O, Shulkes A, Baldwin GS. Gastrin-releasing peptide and cancer. Biochim Biophys Acta. 2006;1766(1):23-41. doi: 10.1016\/j.bbcan.2006.01.003","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"key20250320154037_B18","doi-asserted-by":"crossref","first-page":"101213","DOI":"10.1016\/j.tranon.2021.101213","article-title":"Blocking GRP\/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer","volume":"14","author":"Case","year":"2021","unstructured":"18 Case TC, Merkel A, Ramirez-Solano M, Liu Q, Sterling JA, Jin R. Blocking GRP\/GRP-R signaling decreases expression of androgen receptor splice variants and inhibits tumor growth in castration-resistant prostate cancer. Transl Oncol. 2021 Nov;14(11):101213. doi: 10.1016\/j.tranon.2021.101213","journal-title":"Transl Oncol"},{"issue":"6031","key":"key20250320154037_B19","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/316823a0","article-title":"Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer","volume":"316","author":"Cuttitta","year":"1985","unstructured":"19 Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, et al. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature. 1985;316(6031):823-6. doi: 10.1038\/316823a0","journal-title":"Nature"},{"key":"key20250320154037_B20","doi-asserted-by":"crossref","first-page":"650249","DOI":"10.3389\/fonc.2021.650249","article-title":"Gastrin-releasing peptide receptor in low grade prostate cancer: can it be a better predictor than prostate-specific membrane antigen?","volume":"11","author":"Faviana","year":"2021","unstructured":"20 Faviana P, Boldrini L, Erba PA, Di Stefano I, Manassero F, Bartoletti R, et al. Gastrin-releasing peptide receptor in low grade prostate cancer: can it be a better predictor than prostate-specific membrane antigen? Front Oncol. 2021;11:650249. doi: 10.3389\/fonc.2021.650249","journal-title":"Front Oncol"},{"issue":"2","key":"key20250320154037_B21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000335955","article-title":"he gastrin-releasing peptide receptor as a marker of dysplastic alterations in cervical epithelial cells","volume":"82","author":"Cornelio","year":"2012","unstructured":"21 Cornelio DB, Meurer L, Schwartsmann G, Roesler R. he gastrin-releasing peptide receptor as a marker of dysplastic alterations in cervical epithelial cells. Oncology. 2012;82(2):90-7. doi: 10.1159\/000335955","journal-title":"Oncology"},{"issue":"1","key":"key20250320154037_B22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3892\/mco.2012.7","article-title":"Influence of GRPR and BDNF\/TrkB signaling on the viability of breast and gynecologic cancer cells","volume":"1","author":"Cornelio","year":"2013","unstructured":"22 Cornelio DB, De Farias CB, Prusch DS, Heinen TE, Dos Santos RP, Abujamra AL, et al. Influence of GRPR and BDNF\/TrkB signaling on the viability of breast and gynecologic cancer cells. Mol Clin Oncol. 2013;1(1):148-52.","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"key20250320154037_B23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215540205000802","article-title":"DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH","volume":"50","author":"Shi","year":"2002","unstructured":"23 Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, et al. DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: heating under the influence of pH. J Histochem Cytochem. 2002;50(8):1005-11. doi: 10.1177\/002215540205000802","journal-title":"J Histochem Cytochem"},{"issue":"4732","key":"key20250320154037_B24","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.2999980","article-title":"Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia","volume":"230","author":"Saiki","year":"1985","unstructured":"24 Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230(4732):1350-4. doi: 10.1126\/science.2999980","journal-title":"Science"},{"issue":"Pt 4","key":"key20250320154037_B25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1099\/0022-1317-76-4-1057","article-title":"The use of general primers GP5 and GP6 elongated at their 3\u2019 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR","volume":"76","author":"de Roda Husman","year":"1995","unstructured":"25 de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3\u2019 ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76(Pt 4):1057-62. doi: 10.1099\/0022-1317-76-4-1057","journal-title":"J Gen Virol"},{"issue":"2","key":"key20250320154037_B26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2004.07.026","article-title":"HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes","volume":"328","author":"Boccardo","year":"2004","unstructured":"26 Boccardo E, Noya F, Broker TR, Chow LT, Villa LL. HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology. 2004;328(2):233-43. doi: 10.1016\/j.virol.2004.07.026","journal-title":"Virology"},{"issue":"3","key":"key20250320154037_B27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/carcin\/bgp333","article-title":"Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha","volume":"31","author":"Boccardo","unstructured":"27 Boccardo E, Manzini Baldi CV, Carvalho AF, Rabachini T, Torres C, Barreta LA, et al. Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-alpha. Carcinogenesis 31(3), 521-31. Carcinogenesis. 2010;31(3):521-31. doi: 10.1093\/carcin\/bgp333","journal-title":"Carcinogenesis"},{"issue":"10","key":"key20250320154037_B28","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2967\/jnumed.115.160739","article-title":"Clinical relevance of targeting the gastrin-releasing peptide receptor, somatostatin receptor 2, or chemokine C-X-C motif receptor 4 in breast cancer for imaging and therapy","volume":"56","author":"Dalm","year":"2015","unstructured":"28 Dalm SU, Sieuwerts AM, Look MP, Melis M, van Deurzen CH, Foekens JA, et al. Clinical relevance of targeting the gastrin-releasing peptide receptor, somatostatin receptor 2, or chemokine C-X-C motif receptor 4 in breast cancer for imaging and therapy. J Nucl Med. 2015;56(10):1487-93. doi: 10.2967\/jnumed.115.160739","journal-title":"J Nucl Med"},{"issue":"6","key":"key20250320154037_B29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/PAI.0b013e3182921c52","article-title":"Expression of gastrin-releasing peptide receptor in epidermoid carcinoma of the anal canal","volume":"22","author":"Martins","year":"2014","unstructured":"29 Martins FF, Contu PC, Meurer L, Schwartsmann G, Damin DC. Expression of gastrin-releasing peptide receptor in epidermoid carcinoma of the anal canal. Appl Immunohistochem Mol Morphol. 2014;22(6):459-63. doi: 10.1097\/PAI.0b013e3182921c52","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"key20250320154037_B30","doi-asserted-by":"crossref","first-page":"728088","DOI":"10.3389\/fendo.2021.728088","article-title":"Bombesin receptor family activation and CNS\/neural tumors: review of evidence supporting possible role for novel targeted therapy","volume":"12","author":"Moody","year":"2021","unstructured":"30 Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT. Bombesin receptor family activation and CNS\/neural tumors: review of evidence supporting possible role for novel targeted therapy. Front Endocrinol (Lausanne). 2021;12:728088. doi: 10.3389\/fendo.2021.728088","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20250320154037_B31","doi-asserted-by":"crossref","first-page":"1126426","DOI":"10.3389\/fonc.2023.1126426","article-title":"Human gastrin-releasing peptide receptor expression in women with uterine cervix cancer","volume":"13","author":"Kunos","year":"2023","unstructured":"31 Kunos CA, Fabian D, Napier D, Stonecypher MS, Duncan RM, Hurt J. Human gastrin-releasing peptide receptor expression in women with uterine cervix cancer. Front Oncol. 2023;13:1126426. doi: 10.3389\/fonc.2023.1126426","journal-title":"Front Oncol"},{"issue":"1","key":"key20250320154037_B32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","unstructured":"32 Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol. 2008;111(1):167-77. doi: 10.1097\/01.AOG.0000296488.85807.b3","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key20250320154037_B33","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1038\/s41598-024-68344-4","article-title":"HPV DNA status and clinical history of patients are supplements for accurate reporting of the cytological Pap smear","volume":"14","author":"Ali","year":"2024","unstructured":"33 Ali M, Sinha R, Kumar A, Karim S, Irfan M, Kumar S, et al. HPV DNA status and clinical history of patients are supplements for accurate reporting of the cytological Pap smear. Sci Rep. 2024;14(1):17486. doi: 10.1038\/s41598-024-68344-4","journal-title":"Sci Rep"},{"issue":"31","key":"key20250320154037_B34","doi-asserted-by":"crossref","first-page":"21630","DOI":"10.18632\/oncotarget.24850","article-title":"Strong SOD2 expression and HPV-16\/18 positivity are independent events in cervical cancer","volume":"9","author":"Rabelo-Santos","year":"2018","unstructured":"34 Rabelo-Santos SH, Termini L, Boccardo E, Derchain S, Longatto-Filho A, Andreoli MA, et al. Strong SOD2 expression and HPV-16\/18 positivity are independent events in cervical cancer. Oncotarget. 2018;9(31):21630-40. doi: 10.18632\/oncotarget.24850","journal-title":"Oncotarget"}],"container-title":["Revista Brasileira de Ginecologia e Obstetr\u00edcia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T16:09:31Z","timestamp":1742486971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalrbgo.org\/article\/gastrin-releasing-peptide-receptor-a-promising-new-biomarker-to-identify-cervical-precursor-lesions-and-cancer\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"alternative-id":["10.61622\/rbgo\/2025rbgo4"],"URL":"https:\/\/doi.org\/10.61622\/rbgo\/2025rbgo4","relation":{},"ISSN":["0100-7203","1806-9339"],"issn-type":[{"value":"0100-7203","type":"print"},{"value":"1806-9339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e-rbgo4"}}